D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -97.16% -97.49% -86.89% -67.27%
Total Other Revenue -- -- -- -- --
Total Revenue -- -97.16% -97.49% -86.89% -67.27%
Cost of Revenue 46.66% 67.35% 76.80% 39.34% 26.80%
Gross Profit -52.15% -86.54% -104.97% -58.38% -42.09%
SG&A Expenses 55.95% 60.54% 59.95% 60.00% 52.82%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 45.70% 59.07% 63.76% 71.43% 61.16%
Operating Income -49.35% -70.15% -78.54% -91.44% -78.76%
Income Before Tax -36.59% -69.00% -76.21% -87.92% -76.57%
Income Tax Expenses 78.63% 108.60% -739.05% -739.05% -739.05%
Earnings from Continuing Operations -37.52% -71.14% -75.27% -86.87% -75.46%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -37.52% -71.14% -75.27% -86.87% -75.46%
EBIT -49.35% -70.15% -78.54% -91.44% -78.76%
EBITDA -49.56% -70.71% -79.27% -92.46% -79.56%
EPS Basic 5.49% -10.04% -16.27% -23.63% -21.72%
Normalized Basic EPS 1.99% -2.75% -10.85% -18.03% -16.78%
EPS Diluted 5.49% -10.04% -16.27% -23.63% -21.72%
Normalized Diluted EPS 1.99% -2.75% -10.85% -18.03% -16.78%
Average Basic Shares Outstanding 48.29% 59.43% 54.51% 52.21% 40.28%
Average Diluted Shares Outstanding 48.29% 59.43% 54.51% 52.21% 40.28%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings